Health Canada announces changes aimed at dropping prices of patented drugs
Aug 9 2019 — Kristy Kirkup, The Canadian Press — OTTAWA — The federal government is overhauling the way it regulates the cost of patented medicines, including ending comparisons to the United States — changes that Canada's health minister is billing as the biggest step towards lower drug prices in a generation. Health Canada's long-awaited amendments to patented medicine regulations, unveiled Friday, include allowing the arm's-length Patented Medicine Prices Review Board to […]